1 | .Nusinersen | [1] Nusinersen Nusinersen | [1] Nusinersen
Nusinersen
💬 | [1] SMN2 SMN2 💬 | - | [1] 3 3 💬 |
2 | 0000 | - | - | - | - | [1] 3 3 💬 |
3 | 2011-2012 seasonal flu vaccine Intramuscular | - | - | - | - | [2] 3 3, 113 💬 |
4 | 2011-2012 seasonal flu vaccine Subcutaneous | - | - | - | - | [2] 3 3, 113 💬 |
5 | 3,4-Diaminopyridine Phosphate | [2] Amifampridine Amifampridine, Phosphate ion | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 3 3 💬 |
6 | 4-Aminopyridine | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 3 3, 13 💬 |
7 | 4-cholesten-3-one, oxime | - | - | - | - | [2] 2 2, 3 💬 |
8 | 4-cholesten-3-one,oxime | - | - | - | - | [1] 3 3 💬 |
9 | Adipose derived mesenchymal stem cell | - | - | - | - | [1] 3 3 💬 |
10 | AMIFAMPRIDINA | - | - | - | - | [2] 3 3, 11 💬 |
11 | Amifampridina fosfato | - | - | - | - | [2] 3 3, 11 💬 |
12 | Amifampridine | [1] Amifampridine Amifampridine | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬 |
13 | Amifampridine Phosphate | [2] Amifampridine Amifampridine, Phosphate ion | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [3] 3 3, 11, 12 💬 |
14 | Amifampridine Phosphate 10 MG Oral Tablet | [2] Amifampridine Amifampridine, Phosphate ion | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 3 3 💬 |
15 | Apitegromab | [1] Apitegromab Apitegromab | [1] Apitegromab
Apitegromab
💬 | [1] MSTN MSTN 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 3 3 💬 |
16 | AVXS-101 | - | - | - | - | [1] 3 3 💬 |
17 | AVXS-101 (previously known as scAAV9.CB.SMN) | - | - | - | - | [1] 3 3 💬 |
18 | Biocarn | - | - | - | - | [1] 3 3 💬 |
19 | Branaplam | [1] Branaplam Branaplam | [1] Branaplam
Branaplam
💬 | [1] SMN2 SMN2 💬 | - | [2] 3 3, 8 💬 |
20 | Celecoxib | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬 | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 💬 |
21 | Disease modifying treatments | - | - | - | - | [1] 3 3 💬 |
22 | EVRYSDI | [1] Risdiplam Risdiplam | [1] Risdiplam
Risdiplam
💬 | [1] SMN2 SMN2 💬 | [1] Nucleocytoplasmic transport Nucleocytoplasmic transport 💬 | [1] 3 3 💬 |
23 | EXG001-307 injection | - | - | - | - | [1] 3 3 💬 |
24 | Firdapse | [1] Amifampridine Amifampridine | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 3 3, 11 💬 |
25 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | [1] Amifampridine Amifampridine | [1] Amifampridine
Amifampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 3 3, 11 💬 |
26 | GH | - | - | - | - | [1] 3 3 💬 |
27 | GYM329 | - | - | - | - | [1] 3 3 💬 |
28 | HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY | - | - | - | - | [1] 3 3 💬 |
29 | Hydroxyurea | [1] Hydroxyurea Hydroxyurea | [1] Hydroxyurea
Hydroxyurea
💬 | [1] RRM2 RRM2 💬 | [7] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | [8] 3 3, 13, 19, 20, 65, 85, 86, 284 💬 |
30 | ISIS 396443 | - | - | - | - | [1] 3 3 💬 |
31 | ISIS 396443 (BIIB058) | - | - | - | - | [1] 3 3 💬 |
32 | ISIS 396443, BIIB058 | - | - | - | - | [1] 3 3 💬 |
33 | Itraconazole | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬 | - | - | [6] 3 3, 46, 65, 96, 227, 299 💬 |
34 | Leuprolide | [1] Leuprolide Leuprolide | - | - | - | [5] 1 1, 2, 3, 51, 76 💬 |
35 | LEVOCARNITINE | [1] Levocarnitine Levocarnitine | [1] Levocarnitine
Levocarnitine
💬 | - | - | [3] 3 3, 53, 97 💬 |
36 | LMI070 | - | - | - | - | [2] 3 3, 8 💬 |
37 | Mestinon | [1] Pyridostigmine Pyridostigmine | - | - | - | [3] 3 3, 6, 11 💬 |
38 | Midazolam | [1] Midazolam Midazolam | [1] Midazolam
Midazolam
💬 | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [12] 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬 |
39 | N.a. | - | - | - | - | [10] 3 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 💬 |
40 | Nerve Growth Factor | [1] Nerve Growth Factor Nerve Growth Factor | - | - | - | [3] 3 3, 53, 90 💬 |
41 | Norditropin SimpleXx | [1] Somatotropin Somatotropin | - | - | - | [5] 3 3, 78, 107, 193, 195 💬 |
42 | Norditropin SimpleXx 15 mg/1.5 ml | [1] Somatotropin Somatotropin | - | - | - | [1] 3 3 💬 |
43 | Nursinersen | - | - | - | - | [1] 3 3 💬 |
44 | NUSINERSEN | [1] Nusinersen Nusinersen | [1] Nusinersen
Nusinersen
💬 | [1] SMN2 SMN2 💬 | - | [1] 3 3 💬 |
45 | Nusinersen Injectable Product | [1] Nusinersen Nusinersen | [1] Nusinersen
Nusinersen
💬 | [1] SMN2 SMN2 💬 | - | [1] 3 3 💬 |
46 | NUSINERSEN SODIUM | [1] Nusinersen Nusinersen | [1] Nusinersen
Nusinersen
💬 | [1] SMN2 SMN2 💬 | - | [1] 3 3 💬 |
47 | Nusinersen Treatments | [1] Nusinersen Nusinersen | [1] Nusinersen
Nusinersen
💬 | [1] SMN2 SMN2 💬 | - | [1] 3 3 💬 |
48 | OAV101 | - | - | - | - | [1] 3 3 💬 |
49 | Okrido | - | - | - | - | [1] 3 3 💬 |
50 | Okrido 6mg/mL oral solution | - | - | - | - | [1] 3 3 💬 |
51 | Olesoxime | [1] Olesoxime Olesoxime | [1] Olesoxime
Olesoxime
💬 | - | - | [3] 2 2, 3, 13 💬 |
52 | ONASEMNOGENE ABEPARVOVEC | [1] Onasemnogene abeparvovec Onasemnogene abeparvovec | [1] Onasemnogene abeparvovec
Onasemnogene abeparvovec
💬 | [1] SMN1 SMN1 💬 | - | [1] 3 3 💬 |
53 | Onasemnogene Abeparvovec-xioi | [1] Onasemnogene abeparvovec Onasemnogene abeparvovec | [1] Onasemnogene abeparvovec
Onasemnogene abeparvovec
💬 | [1] SMN1 SMN1 💬 | - | [1] 3 3 💬 |
54 | Orfiril Saft | - | - | - | - | [1] 3 3 💬 |
55 | PARACETAMOL | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [6] 3 3, 6, 13, 35, 46, 49 💬 |
56 | Paracetamol 120Mg/5mL Oral Suspension | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬 | [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 3 3 💬 |
57 | PHENYLBUTYRATE | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [12] 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 💬 |
58 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [32] 2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 💬 |
59 | Placebo | - | - | - | - | [28] 3 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
60 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
61 | PREDNISOLONE SODIUM PHOSPHATE | [2] Phosphate ion Phosphate ion, Prednisolone | [1] Prednisolone
Prednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 3 3, 13, 97 💬 |
62 | Previously termed sc.AAV9.CB.SMN and AVXS-101 | - | - | - | - | [1] 3 3 💬 |
63 | Pyridostigmine | [1] Pyridostigmine Pyridostigmine | - | - | - | [4] 3 3, 6, 11, 256 💬 |
64 | Pyridostigmine Bromide | [1] Pyridostigmine Pyridostigmine | - | - | - | [3] 3 3, 6, 256 💬 |
65 | RELDESEMTIV | [1] Reldesemtiv Reldesemtiv | [1] Reldesemtiv
Reldesemtiv
💬 | [1] TNNC2 TNNC2 💬 | [1] Calcium signaling pathway Calcium signaling pathway 💬 | [2] 2 2, 3 💬 |
66 | Reldesemtiv 150 mg | [1] Reldesemtiv Reldesemtiv | [1] Reldesemtiv
Reldesemtiv
💬 | [1] TNNC2 TNNC2 💬 | [1] Calcium signaling pathway Calcium signaling pathway 💬 | [1] 3 3 💬 |
67 | Reldesemtiv 450 mg | [1] Reldesemtiv Reldesemtiv | [1] Reldesemtiv
Reldesemtiv
💬 | [1] TNNC2 TNNC2 💬 | [1] Calcium signaling pathway Calcium signaling pathway 💬 | [1] 3 3 💬 |
68 | RILUZOLE | [1] Riluzole Riluzole | [1] Riluzole
Riluzole
💬 | [14] GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [23] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [9] 2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬 |
69 | Risdiplam | [1] Risdiplam Risdiplam | [1] Risdiplam
Risdiplam
💬 | [1] SMN2 SMN2 💬 | [1] Nucleocytoplasmic transport Nucleocytoplasmic transport 💬 | [1] 3 3 💬 |
70 | RO6885247 | - | - | - | - | [1] 3 3 💬 |
71 | RO6885247/F02 | - | - | - | - | [1] 3 3 💬 |
72 | RO6885247/F03 | - | - | - | - | [1] 3 3 💬 |
73 | RO7034067 | - | - | - | - | [1] 3 3 💬 |
74 | RO7034067 / F12 | - | - | - | - | [1] 3 3 💬 |
75 | RO7034067 / F13 | - | - | - | - | [1] 3 3 💬 |
76 | RO7034067/F06 + solvente (RO | - | - | - | - | [1] 3 3 💬 |
77 | RO7034067/F06 with solvent (RO7034067/F08) | - | - | - | - | [1] 3 3 💬 |
78 | RO7034067/F07 + solvente (RO | - | - | - | - | [1] 3 3 💬 |
79 | RO7034067/F07 with solvent (RO7034067/F09) | - | - | - | - | [1] 3 3 💬 |
80 | RO7034067/F12 | - | - | - | - | [1] 3 3 💬 |
81 | RO7034067/F13 | - | - | - | - | [1] 3 3 💬 |
82 | RO7090919 | - | - | - | - | [1] 3 3 💬 |
83 | RO7204239 | - | - | - | - | [2] 3 3, 113 💬 |
84 | RO7204239/F01-01 | - | - | - | - | [1] 3 3 💬 |
85 | RVG 03820 | - | - | - | - | [1] 3 3 💬 |
86 | Salbutamol | [1] Salbutamol Salbutamol | [1] Albuterol
Albuterol
💬 | [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 3 3, 11, 49, 85, 86, 111, 256, 299 💬 |
87 | Sesame oil | [1] Sesame oil Sesame oil | [1] Sesame oil
Sesame oil
💬 | - | - | [1] 3 3 💬 |
88 | SESAME OIL, REFINED | [1] Sesame oil Sesame oil | [1] Sesame oil
Sesame oil
💬 | - | - | [1] 3 3 💬 |
89 | SMART | - | - | - | - | [1] 3 3 💬 |
90 | Sodium phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [4] 2 2, 3, 8, 251 💬 |
91 | Sodium phenylbutyrate (NaPB) | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 3 3 💬 |
92 | Somatotropin | [1] Somatotropin Somatotropin | - | - | - | [4] 3 3, 65, 78, 236 💬 |
93 | Somatropin | [1] Somatotropin Somatotropin | - | - | - | [19] 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬 |
94 | Spinraza | [1] Nusinersen Nusinersen | [1] Nusinersen
Nusinersen
💬 | [1] SMN2 SMN2 💬 | - | [1] 3 3 💬 |
95 | SRK-015 | - | - | - | - | [1] 3 3 💬 |
96 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬 |
97 | Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide | - | - | - | - | [1] 3 3 💬 |
98 | Taldefgrobep alfa | [1] Talditercept alfa Talditercept alfa | [1] Taldefgrobep alfa
Taldefgrobep alfa
💬 | [1] MSTN MSTN 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 3 3 💬 |
99 | Testosterone | [1] Testosterone Testosterone | [1] Testosterone
Testosterone
💬 | [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [8] 1 1, 2, 3, 13, 60, 76, 78, 113 💬 |
100 | TRO19622 | - | - | - | - | [2] 2 2, 3 💬 |
101 | Valproate | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [6] 2 2, 3, 90, 102, 233, 256 💬 |
102 | VALPROATE SODIUM | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 3 3 💬 |
103 | Valproate, Levocarnitine | [2] Levocarnitine Levocarnitine, Valproic acid | [2] Valproic acid
Valproic acid
,
Levocarnitine
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 3 3 💬 |
104 | Valproic Acid | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [7] 3 3, 5, 26, 65, 90, 222, 256 💬 |
105 | Valproic Acid (VPA) | [1] Valproic acid Valproic acid | [1] Valproic acid
Valproic acid
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 3 3 💬 |
106 | Valproic Acid and Levocarnitine | [2] Levocarnitine Levocarnitine, Valproic acid | [2] Valproic acid
Valproic acid
,
Levocarnitine
💬 | [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 3 3 💬 |
107 | VOLMAX*30CPR 4MG R.P. | - | - | - | - | [1] 3 3 💬 |
108 | VPA | - | - | - | - | [1] 3 3 💬 |
109 | Zolgensma | [1] Onasemnogene abeparvovec Onasemnogene abeparvovec | [1] Onasemnogene abeparvovec
Onasemnogene abeparvovec
💬 | [1] SMN1 SMN1 💬 | - | [1] 3 3 💬 |
110 | Zolgensma 2 x 1013 vector genomes/mL solution for infusion | [1] Onasemnogene abeparvovec Onasemnogene abeparvovec | [1] Onasemnogene abeparvovec
Onasemnogene abeparvovec
💬 | [1] SMN1 SMN1 💬 | - | [1] 3 3 💬 |
111 | Zolgensma 2 x 1013 vg (vector genomes)/mL solution for infusion | [1] Onasemnogene abeparvovec Onasemnogene abeparvovec | [1] Onasemnogene abeparvovec
Onasemnogene abeparvovec
💬 | [1] SMN1 SMN1 💬 | - | [1] 3 3 💬 |